OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacogenomics in clinical practice to prevent risperidone-induced hyperprolactinemia in autism spectrum disorder
Mohitosh Biswas, Natchaya Vanwong, Chonlaphat Sukasem
Pharmacogenomics (2022) Vol. 23, Iss. 8, pp. 493-503
Open Access | Times Cited: 7
Mohitosh Biswas, Natchaya Vanwong, Chonlaphat Sukasem
Pharmacogenomics (2022) Vol. 23, Iss. 8, pp. 493-503
Open Access | Times Cited: 7
Showing 7 citing articles:
Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications
Mohitosh Biswas, Natchaya Vanwong, Chonlaphat Sukasem
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 4
Mohitosh Biswas, Natchaya Vanwong, Chonlaphat Sukasem
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 4
Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents
Amarachi A. Kanu, Michelle M. Johnston, Ethan A. Poweleit, et al.
Journal of Child and Adolescent Psychopharmacology (2024) Vol. 34, Iss. 1, pp. 34-41
Closed Access | Times Cited: 3
Amarachi A. Kanu, Michelle M. Johnston, Ethan A. Poweleit, et al.
Journal of Child and Adolescent Psychopharmacology (2024) Vol. 34, Iss. 1, pp. 34-41
Closed Access | Times Cited: 3
Review of Pharmacogenomics of Psychiatric Comorbidities in Autism Spectrum Disorder
Aida Álvarez, Valentín Bote, Cristina Lamborena, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 14, pp. 781-791
Closed Access | Times Cited: 1
Aida Álvarez, Valentín Bote, Cristina Lamborena, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 14, pp. 781-791
Closed Access | Times Cited: 1
Pharmacogenomics of Chloroquine and Hydroxychloroquine: Current Evidence and Future Implications
Mohitosh Biswas, Chonlaphat Sukasem
Pharmacogenomics (2023) Vol. 24, Iss. 15, pp. 831-840
Closed Access | Times Cited: 1
Mohitosh Biswas, Chonlaphat Sukasem
Pharmacogenomics (2023) Vol. 24, Iss. 15, pp. 831-840
Closed Access | Times Cited: 1
Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study
Laura de Miguel, Pura Ballester, Cecilia Egoavil, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1496-1496
Open Access | Times Cited: 1
Laura de Miguel, Pura Ballester, Cecilia Egoavil, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1496-1496
Open Access | Times Cited: 1
Highlights of 2022 and looking forward to 2023 at Pharmacogenomics
Sarah Jones
Pharmacogenomics (2023) Vol. 24, Iss. 2, pp. 69-71
Closed Access
Sarah Jones
Pharmacogenomics (2023) Vol. 24, Iss. 2, pp. 69-71
Closed Access
Nutrition Can Modify Gut-Brain Axis and Medication Induced Metabolic Disorders in Autism Spectrum Disorder- A Hypothesis
Kimia Moiniafshari
International Journal of Pharmaceutical and Bio-Medical Science (2022) Vol. 02, Iss. 09
Open Access
Kimia Moiniafshari
International Journal of Pharmaceutical and Bio-Medical Science (2022) Vol. 02, Iss. 09
Open Access
